R. Wasserman

DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae.

J. Wang, T. Andoh, M. Hamatake, 1995, Cancer research.

the Antitumor Drug Amsacrine Analysis of Yeast DNA Topoisomerase II Mutants Resistant to Updated

James C. Wang, R. Wasserman, 2006 .

Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine.

J. Wang, James C. Wang, R. Wasserman, 1994, Cancer research.

in Yeast α Human DNA Topoisomerase II Topoisomerases : Expression of a Functional Recombinant Use of Yeast in the Study of Anticancer Drugs Targeting DNA Updated

L. Fisher, James C. Wang, C. Austin, 2006 .

Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase II.

J. Wang, M. Jannatipour, P. Harbury, 1992, Cancer research.

Expression, Domain Structure, and Enzymatic Properties of an Active Recombinant Human DNA Topoisomerase IIβ (*)

L. Fisher, James C. Wang, E. Willmore, 1995, The Journal of Biological Chemistry.

Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast.

J. Wang, L. Fisher, C. Austin, 1993, Cancer research.

Mechanistic studies of amsacrine-resistant derivatives of DNA topoisomerase II. Implications in resistance to multiple antitumor drugs targeting the enzyme.

J. Wang, R. Wasserman, 1994, The Journal of biological chemistry.